• Harnessing Sodium Ascorbate for Translational Glioblastoma R

  2026-04-28

  This thought-leadership article explores the mechanistic underpinnings and strategic value of sodium ascorbate—a bioavailable mineral salt of ascorbic acid—in preclinical glioblastoma models, drawing connections between ROS-mediated tumor cell death and emerging biomarker-driven immunotherapy paradigms. The piece integrates robust evidence, contextualizes APExBIO's Sodium Ascorbate (SKU B1834) within the evolving cancer research landscape, and offers actionable guidance for translational scientists.

• Lamotrigine in CNS and Cardiac Research: Workflows & Optimiz

  2026-04-28

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) from APExBIO is a high-purity tool for dissecting sodium channel and serotonin signaling in translational models of epilepsy and cardiac arrhythmias. This article delivers stepwise protocols, advanced troubleshooting, and practical insights leveraging the latest high-throughput BBB permeability innovations for reliable CNS and cardiac research outcomes.

• Temozolomide: Applied Workflows for DNA Repair and Glioma Re

  2026-04-27

  Temozolomide, a small-molecule alkylating agent, enables precision modeling of DNA damage and chemotherapy resistance in cancer research. This guide translates the latest reference findings and real-world troubleshooting into actionable workflows, maximizing reproducibility in glioma and DNA repair mechanism studies.

• Z-YVAD-FMK Caspase-1 Inhibitor: Precision Tools for Apoptosi

  2026-04-27

  Z-YVAD-FMK stands out as a potent, selective caspase-1 inhibitor, empowering researchers to dissect inflammasome signaling with confidence. Its robust performance in apoptosis and pyroptosis workflows, when paired with optimized protocols, ensures reproducible results even in challenging cancer and cell death studies.

• Bazedoxifene: Selective Estrogen Receptor Modulator for Adva

  2026-04-26

  Bazedoxifene empowers research teams to dissect estrogen receptor signaling and bone mineral density enhancement with unmatched specificity. This third-generation SERM offers tissue-selective activity, robust in vitro and in vivo profiles, and seamless integration into osteoporosis treatment research.

• Chloroquine diphosphate (A8628): Reliable Autophagy Modulati

  2026-04-25

  This article addresses common lab challenges in autophagy assays and cancer research, offering scenario-driven guidance with Chloroquine diphosphate (SKU A8628). Drawing on peer-reviewed evidence and real-world workflow needs, it demonstrates how this reagent enables reproducible, data-backed results and simplifies experimental optimization.

• Nuclear cGAS Suppresses L1 Retrotransposition via TRIM41-ORF

  2026-04-24

  This study reveals that nuclear cGAS restricts LINE-1 (L1) retrotransposition by enhancing TRIM41-mediated ubiquitination and degradation of ORF2p, thereby promoting genome stability. The mechanistic insights into cGAS phosphorylation and its regulatory axis offer new perspectives on the interplay between DNA damage response and retrotransposon control, with potential implications for aging and cancer research.

• RG7388 (MDM2 Antagonist): Selective p53 Activation in Cancer

  2026-04-24

  RG7388 is a highly potent, selective oral MDM2 antagonist that disrupts the p53-MDM2 interaction, enabling rapid p53 pathway activation and cancer cell apoptosis. Preclinical evidence shows nanomolar efficacy and synergy with chemotherapy and radiation in wild-type p53 tumor models. This article summarizes mechanism, benchmarks, and workflow integration, with precise protocol recommendations and pitfalls.

• Carboplatin in Preclinical Oncology: Quantitative Protocols

  2026-04-23

  Discover the pivotal role of Carboplatin as a platinum-based DNA synthesis inhibitor in preclinical oncology research. This article offers a protocol-driven analysis and interprets recent evidence to optimize experimental design and decision-making.

• Bivalent mRNA Vaccine RQ3025 Shows Broad Efficacy in Preclin

  2026-04-23

  The referenced study presents a bivalent mRNA vaccine (RQ3025) designed to induce broad-spectrum immunity against diverse SARS-CoV-2 variants in animal models. Through advanced immunological and histopathological analyses, the research establishes RQ3025’s improved neutralizing antibody breadth and safety profile, providing a foundation for further translational development.

• Rapid Conversion of Atrial Fibrillation: Vernakalant’s Phase

  2026-04-22

  This article analyzes a pivotal phase 3 randomized trial evaluating vernakalant hydrochloride for rapid conversion of atrial fibrillation (AF) to sinus rhythm. The study demonstrates vernakalant’s significant efficacy over placebo for short-duration AF, with a favorable safety profile, and discusses implications for acute rhythm management in clinical and translational research.

• Reelin-SFK Signaling Is Essential for Ketamine's Antidepress

  2026-04-22

  This study uncovers the crucial role of synaptic Reelin-Apoer2-Src family kinase (SFK) signaling in enabling ketamine-induced synaptic plasticity and behavioral antidepressant effects. Disruption of this pathway blocks ketamine’s efficacy, providing mechanistic insight into treatment-resistant depression and informing experimental strategies.

• Ellagic Acid: CK2 Inhibitor Workflows for Cancer & Senescenc

  2026-04-21

  Ellagic acid, a selective ATP-competitive CK2 inhibitor, stands out for its robust performance in cancer biology and oxidative stress assays. By leveraging precise workflows and troubleshooting insights, researchers can harness its unique properties for apoptosis, senescence, and advanced cell signaling studies.

• Phosphatase Inhibitor Cocktail 1: Precision in Protein Phosp

  2026-04-21

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) empowers researchers to preserve protein phosphorylation with exceptional fidelity, streamlining phosphoproteomic analyses and complex signaling assays. Its robust inhibition of alkaline and serine/threonine phosphatases protects dynamic phosphorylation states, facilitating accurate and reproducible results in even the most challenging tissue and cell lysate workflows.

• Bismuth Subsalicylate: Practical Guide for GI Disorder Resea

  2026-04-20

  Bismuth Subsalicylate (SKU A8382) provides a reliable, high-purity tool for studying inflammation and gastrointestinal disorder mechanisms, particularly in workflows targeting prostaglandin pathway modulation and diarrhea treatment research. It is suited for in vitro and ex vivo applications where stability, specificity, and protocol clarity are critical, but should not be used in diagnostic or therapeutic contexts.

406 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page